Literature DB >> 14592589

Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease.

Jane E Ramsay1, Frances Stewart, Ian A Greer, Naveed Sattar.   

Abstract

Epidemiological studies have recently demonstrated a relationship between pre-eclampsia and coronary heart disease. Insulin resistance has been implicated as a common factor. We have demonstrated, for the first time, using laser Doppler imaging in vivo, impaired microvascular function in women 15-25 years following a pregnancy complicated by pre-eclampsia. Thus, microvascular dysfunction, which is associated with insulin resistance, may be a predisposing vascular mechanism for both coronary heart disease and pre-eclampsia. Pregnancies complicated by pre-eclampsia may identify women at risk of vascular disease in later life and may provide the opportunity for lifestyle and risk factor modification to alter maternal vascular disease risk.

Entities:  

Mesh:

Year:  2003        PMID: 14592589

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  30 in total

1.  eNOS deficiency acts through endothelin to aggravate sFlt-1-induced pre-eclampsia-like phenotype.

Authors:  Feng Li; John R Hagaman; Hyung-Suk Kim; Nobuyo Maeda; J Charles Jennette; James E Faber; S Ananth Karumanchi; Oliver Smithies; Nobuyuki Takahashi
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

2.  Preterm delivery of a first child and subsequent mothers' risk of ischaemic heart disease: a nested case-control study.

Authors:  Olivier Nardi; Mahmoud Zureik; Dominique Courbon; Pierre Ducimetière; Françoise Clavel-Chapelon
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2006-04

3.  The profile analysis of circular RNAs in human placenta of preeclampsia.

Authors:  Wenbo Zhou; Huiyan Wang; Xian Wu; Wei Long; Fangxiu Zheng; Jing Kong; Bin Yu
Journal:  Exp Biol Med (Maywood)       Date:  2018-11-20

Review 4.  Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk.

Authors:  Carolina Valdiviezo; Vesna D Garovic; Pamela Ouyang
Journal:  Clin Cardiol       Date:  2012-03       Impact factor: 2.882

Review 5.  Gestational hypoxia and epigenetic programming of brain development disorders.

Authors:  Qingyi Ma; Fuxia Xiong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2014-09-26       Impact factor: 7.851

6.  Placental hypoxia-induced alterations in vascular function, morphology, and endothelial barrier integrity.

Authors:  Philippe Vangrieken; Alex H V Remels; Salwan Al-Nasiry; Aalt Bast; Ger M J Janssen; Ulrike von Rango; Daan Vroomans; Yannick C W Pinckers; Frederik J van Schooten; Paul M H Schiffers
Journal:  Hypertens Res       Date:  2020-07-30       Impact factor: 3.872

Review 7.  Maternal preeclampsia and risk for cardiovascular disease in offspring.

Authors:  Guadalupe Herrera-Garcia; Stephen Contag
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

8.  10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: the HyRAS study.

Authors:  Wietske Hermes; Arie Franx; Maria G van Pampus; Kitty W Bloemenkamp; Joris A van der Post; Martina Porath; Gabrielle Ponjee; Jouke T Tamsma; Ben W Mol; Christianne J de Groot
Journal:  BMC Pregnancy Childbirth       Date:  2010-06-01       Impact factor: 3.007

9.  Causes and mechanisms of intrauterine hypoxia and its impact on the fetal cardiovascular system: a review.

Authors:  Damian Hutter; John Kingdom; Edgar Jaeggi
Journal:  Int J Pediatr       Date:  2010-10-19

10.  Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR study.

Authors:  Alain Stepanian; Soraya Benchenni; Tiphaine Beillat-Lucas; Sophie Omnes; Fannie Defay; Edith Peynaud-Debayle; Gabriel Baron; Agnès Le Querrec; Michel Dreyfus; Laurence Salomon; Vassilis Tsatsaris; Dominique de Prost; Laurent Mandelbrot
Journal:  PLoS One       Date:  2009-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.